Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis

Journal of Clinical Microbiology

Volumn 53, Issue 1, 2015, Pages 248-254

  Oliva, A ^a   Flori, P ^b,c   Hennequin, C ^d,e,f,g   Dubus, J C ^h   Reynaud Gaubert, M ^a   Charpin, D ⁱ   Vergnon, J M ^b,j   Gay, P ^b   Colly, A ^b   Piarroux, R ^a,h   Pelloux, H ^k   Ranquea, S ^a,h  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e INSERM   (France)

^f Assistance publique Hôpitaux de Paris   (France)

^g HÔPITAL SAINT ANTOINE   (France)

^h TIMONE HOSPITAL   (France)

ⁱ HÔPITAL NORD   (France)

^j Jean Monnet University   (France)

^k UNIV GRENOBLE ALPES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLOMA; ASPERGILLOSIS; ASPERGILLUS WESTERN BLOT IGG KIT; BLOOD ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FUNGAL COLONIZATION; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITIN DETECTION TEST; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; NONHUMAN; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING; ASPERGILLUS; CASE CONTROL STUDY; CHRONIC DISEASE; IMMUNOLOGY; REPRODUCIBILITY;

ASPERGILLUS;

DIAGNOSTIC KIT; FUNGUS ANTIBODY; IMMUNOGLOBULIN G;

ANTIBODIES, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHRONIC DISEASE; HUMANS; IMMUNOGLOBULIN G; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84919483031     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02690-14     Document Type: Article

References (25)

1. Sherif R, Segal BH. 2010. Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications. Curr Opin Pulm Med 16:242-250. http://dx.doi.org/10.1097/MCP.0b013e328337d6de.
2. Zmeili OS, Soubani AO. 2007. Pulmonary aspergillosis: a clinical update. QJM 100:317-334. http://dx.doi.org/10.1093/qjmed/hcm035.
3. Nam H-S, Jeon K, Um S-W, Suh GY, Chung MP, Kim H, Kwon OJ, Koh W-J. 2010. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis 14:e479-e482. http://dx.doi.org/10.1016/j.ijid.2009.07.011.
4. Jewkes J, Kay PH, Paneth M, Citron KM. 1983. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 38:572-578. http://dx.doi.org/10.1136/thx.38.8.572.
5. Kurup VP. 2005. Aspergillus antigens: which are important? Med Mycol 43(Suppl 1):S189-S196. http://dx.doi.org/10.1080/13693780500064763.
6. Persat F. 2012. Aspergillus serology, from yesterday to today for tomorrow. J Mycol Med 22:72-82. (In French.) http://dx.doi.org/10.1016/j.mycmed.2012.01.004.
7. Van Toorenenbergen AW. 2012. Between-laboratory quality control of automated analysis of IgG antibodies against Aspergillus fumigatus. Diagn Microbiol Infect Dis 74:278-281. http://dx.doi.org/10.1016/j.diagmicrobio.2012.07.002.
8. Kauffmann HF, De Vries K. 1980. Antibodies against Aspergillus fumigatus II: identification and quantification by means of crossed immunoelectrophoresis. Int Arch Allergy Appl Immunol 62:265-275. http://dx.doi.org/10.1159/000232522.
9. Baxter CG, Denning DW, Jones AM, Todd A, Moore CB, Richardson MD. 2013. Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis. Clin Microbiol Infect 19:E197-E204. http://dx.doi.org/10.1111/1469-0691.12133.
10. Franck J, Garin YJ-F, Dumon H. 2008. LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection. J Clin Microbiol 46:2334-2338. http://dx.doi.org/10.1128/JCM.00182-08.
11. Guan M. 2007. Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus. Clin Vaccine Immunol 14:649-659. http://dx.doi.org/10.1128/CVI.00393-06.
12. Fourneret-Vivier A, Lebeau B, Mallaret MR, Brenier-Pinchart MP, Brion JP, Pinel C, Garban F, Pison C, Hamidfar R, Plantaz D, Pelloux H, Grillot R. 2006. Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000 -2002). J Hosp Infect 62:22-28. http://dx.doi.org/10.1016/j.jhin.2005.06.013.
13. Jubin V, Ranque S, Stremler Le Bel N, Sarles J, Dubus J-C. 2010. Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Pediatr Pulmonol 45:764-771. http://dx.doi.org/10.1002/ppul.21240.
14. Garnaud C, Brenier-Pinchart M-P, Thiebaut-Bertrand A, Hamidfar R, Quesada J-L, Bosseray A, Lebeau B, Mallaret M-R, Maubon D, Saint-Raymond C, Pinel C, Hincky V, Plantaz D, Cornet M, Pelloux H. 2012. Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital. J Infect 65:559-567. http://dx.doi.org/10.1016/j.jinf.2012.08.006.
15. Izumikawa K, Tashiro T, Tashiro M, Takazono T, Kosai K, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Hayashi T, Yanagihara K, Nagayasu T, Kohno S. 2014. Pathogenesis and clinical features of chronic pulmonary aspergillosis: is it possible to distinguish CNPA and CCPA clinically? J Infect Chemother 20:208-212. http://dx.doi.org/10.1016/j.jiac.2013.10.016.
16. Fricker-Hidalgo H, Coltey B, Llerena C, Renversez J-C, Grillot R, Pin I, Pelloux H, Pinel C. 2010. Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Clin Vaccine Immunol 17:1330-1336. http://dx.doi.org/10.1128/CVI.00200-10.
17. Burke DS, Redfield RR, Putman P, Alexander SS. 1987. Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. J Clin Microbiol 25:81-84.
18. Zoller L, Burkard S, Schafer H. 1991. Validity of Western immunoblot band patterns in the serodiagnosis of Lyme borreliosis. J Clin Microbiol 29:174-182.
19. Simán JH, Engstrand L, Berglund G, Florén C-H, Forsgren A. 2005. Evaluation of Western blot CagA seropositivity in Helicobacter pyloriseropositive and -seronegative subjects. Clin Diagn Lab Immunol 12:304-309. http://dx.doi.org/10.1128/CDLI.12.2.304-309.2005.
20. Barberan J, Alcazar B, Malmierca E, Garcia de la Llana F, Dorca J, Del Castillo D, Villena V, Hernandez-Febles M, Garcia-Perez F-J, Granizo J-J, Gimenez M-J, Aguilar L, ASP Investigator Group. 2012. Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection? BMC Infect Dis 12:295. http://dx.doi.org/10.1186/1471-2334-12-295.
21. Bardana EJ, Jr, Sobti KL, Cianciulli FD, Noonan MJ. 1975. Aspergillus antibody in patients with cystic fibrosis. Am J Dis Child 129:1164-1167.
22. Tashiro T, Izumikawa K, Tashiro M, Takazono T, Morinaga Y, Yamamoto K, Imamura Y, Miyazaki T, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Kohno S. 2011. Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward. Med Mycol 49:581-587. http://dx.doi.org/10.3109/13693786.2010.548084.
23. Fillaux J, Brémont F, Murris M, Cassaing S, Tétu L, Segonds C, Pipy B, Magnaval JF. 2014. Aspergillus sensitization or carriage in cystic fibrosis patients. Pediatr Infect Dis J 33:680-686. http://dx.doi.org/10.1097/INF.0000000000000231.
24. Speirs JJ, Van der Ent CK, Beekman JM. 2012. Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis. Curr Opin Pulm Med 18:632-638. http://dx.doi.org/10.1097/MCP.0b013e328358d50b.
25. De Vrankrijker AMM, Van der Ent CK, Van Berkhout FT, Stellato RK, Willems RJL, Bonten MJM, Wolfs TFW. 2011. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? Clin Microbiol Infect 17:1381-1386. http://dx.doi.org/10.1111/j.1469-0691.2010.03429.x.